genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2012
Diabetic retinopathy
Insights
Ocular Therapeutics Target the Retina
Industry News
Promedior Raises $21.5M to Progress Fibrotic Diseases Pipeline
Cancer
Silence and InteRNA Partner to Develop AtuPlex-Formulated Anticancer miRNAs
News
ReNeuron Licenses Schepens IP for Human Retinal Precursor Cell Therapies
Industry News
ThromboGenics Pockets €56M in Private Placement
Drug Discovery
Pfizer Taps Biovista for Drug Repositioning Capabilities
News
ThromboGenics’ Microplasmin Succeeds in Second Late-Stage VMA Study
Insights
Promise of Regenerative Medicine Closer to Reality
News
Pipex Pharmaceuticals Expands Oral Flupirtine License
News
Charlesson Awarded Almost $1.6M from NIH to Advance AMD Mouse Model and Ocular Disease Drug Candidate
1
2
3
Page 2 of 3
Scroll Up
Scroll Up
